Ligand Pharmaceuticals (LGND) Q3 2020 Earnings

3AugConfirmed
Q4 2019
Q1 2020
Q2 2020
Q3 2020
0.49
0.66
0.83
1

Details

Expected EPS
0.76
Actual EPS
1
Surprise EPS
0.24
Surprise Percent
+31.58%

Description

Ligand Pharmaceuticals (LGND) has reported earnings of 1 per share for Q3 2020.

0 Comments

Share your thoughts